Industry News
KRASG12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
Two-year follow up of the CodeBreaK100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile
Two-year follow up of the CodeBreaK100 clinical trial demonstrated prolonged tumor responses and a favorable safety profile
Patients with recurrent lesions genetically distinct from the primary tumor may require different treatment
AACR President David A. Tuveson will chair the symposium titled: Aging, Stress, and Cancer.
AACR President David A. Tuveson says clinicians will be ready and waiting before the cancer appears in the future
Researchers have found that a third COVID-19 vaccine increases vaccine effectiveness
A new era in sample processing and characterization
SelectScience editors will be reporting the latest news from this year’s AACR annual meeting. Detailed here, are some of the key things to look out for